| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 237 |
| 1 | AZATHIOPRINE | 38 |
| 2 | PREDNISONE | 35 |
| 3 | INFLIXIMAB | 33 |
| 4 | USTEKINUMAB | 30 |
| 5 | VEDOLIZUMAB | 29 |
| 6 | PREDNISOLONE | 21 |
| 7 | PREDNISOLONE ORAL | 21 |
| 8 | PREDNISOLONE ORAL SOLUTION | 21 |
| 9 | METHOTREXATE SODIUM | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONTRUZANT | 8 | 0.0153 |
| 1 | ZOLBETUXIMAB | 4 | 0.0026 |
| 2 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 3 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 4 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 5 | CISATRACURIUM BESYLATE | 2 | 0.0009 |
| 6 | ADALIMUMAB-AFZB | 2 | 0.0007 |
| 7 | MESALAMINE | 19 | 0.0007 |
| 8 | HYALURONATE SODIUM | 1 | 0.0007 |
| 9 | GEMFIBROZIL | 7 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 65 |
| 1 | Interleukin-23 Antagonist [EPC] | 56 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 56 |
| 3 | Purine Antimetabolite [EPC] | 38 |
| 4 | Integrin Receptor Antagonist [EPC] | 31 |
| 5 | Interleukin-12 Antagonist [EPC] | 30 |
| 6 | Aminosalicylate [EPC] | 27 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 25 |
| 8 | Proton Pump Inhibitor [EPC] | 23 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 4 | 0.0026 |
| 1 | Interleukin-23 Antagonist [EPC] | 56 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 3 | Purine Antimetabolite [EPC] | 38 | 0.0004 |
| 4 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 5 | Integrin Receptor Antagonist [EPC] | 31 | 0.0004 |
| 6 | Interleukin-12 Antagonist [EPC] | 30 | 0.0003 |
| 7 | Aminosalicylate [EPC] | 27 | 0.0003 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 9 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |